Yogita Sharma
Overview
Explore the profile of Yogita Sharma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma Y, Sridevi P, Bhat D, Surti S, Sarmah J, Sudhakar G, et al.
Int J Health Plann Manage
. 2025 Mar;
PMID: 40070016
This study addresses significant healthcare access challenges faced by India's 104 million-strong tribal population, who are among the most disadvantaged and typically live in hilly rural and remote areas with...
2.
Sekhar L, Govindarajan Venguidesvarane A, Thiruvengadam G, Sharma Y, Venugopal V, Rengarajan S, et al.
PLoS One
. 2024 Dec;
19(12):e0315464.
PMID: 39724031
Several epidemiological studies have examined the respiratory consequences of occupational exposure to volatile organic compounds (VOCs). However, their effects on paint industry workers in organised and unorganised occupational sectors vary....
3.
Sharma Y, Jain A, Gupta P, Tiwari V, Gupta A, Bhargava V, et al.
Indian J Nephrol
. 2024 Dec;
34(6):654-656.
PMID: 39649312
Neural epidermal growth factor-like 1 (NELL-1) is responsible for a substantial proportion of cases of PLA2R-negative primary membranous nephropathy (MN). To investigate the occurrence, association, and treatment responses, we carried...
4.
Bhat D, Sharma Y, Sridevi P, Surti S, Sarmah J, Ranjit M, et al.
J Racial Ethn Health Disparities
. 2024 Nov;
PMID: 39503970
Sickle cell disease (SCD) is a genetic blood disorder presenting a substantial public health challenge. India, holding the second-highest prevalence globally, exhibits diverse clinical manifestations. The recently launched National SCD...
5.
Sharma Y, Lo R, Tomilin V, Ha K, Deremo H, Pareek A, et al.
JCI Insight
. 2024 Oct;
9(22).
PMID: 39405114
Mutations in the CLCNKB gene (1p36), encoding the basolateral chloride channel ClC-Kb, cause type 3 Bartter syndrome. We identified a family with a mixed Bartter/Gitelman phenotype and early-onset kidney failure...
6.
Sharma Y, Tiwari V, Tyagi V, Bhargava V, Gupta A, Malik M, et al.
Kidney Int
. 2024 Sep;
106(4):760.
PMID: 39304277
No abstract available.
7.
Ahlawat S, Shukla B, Singh V, Sharma Y, Choudhary P, Rao A
Biotechnol Adv
. 2024 Jul;
75:108415.
PMID: 39033836
Glycosylated bacteriocins, known as glycocins, were first discovered in 2011. These bioactive peptides are produced by bacteria to gain survival advantages. They exhibit diverse types of glycans and demonstrate varied...
8.
Sharma Y, Bhat D, Sridevi P, Surti S, Ranjit M, Sarmah J, et al.
Blood Cells Mol Dis
. 2024 Jul;
109:102873.
PMID: 39024737
Background: Sickle cell disease (SCD) registries provide crucial real-world data on demographics, epidemiology, healthcare, patient outcomes, and treatment efficacy. This paper presents findings from the Indian SCD Registry (ISCDR) on...
9.
Sharma Y, Laison E, Philippsen T, Ma J, Kong J, Ghaemi S, et al.
Lancet Reg Health Am
. 2024 Mar;
32:100706.
PMID: 38495312
Tick-borne diseases (TBD) remain prevalent worldwide, and risk assessment of tick habitat suitability is crucial to prevent or reduce their burden. This scoping review provides a comprehensive survey of models...
10.
Babu B, Sharma Y, Sridevi P, Surti S, Bhat D, Ranjit M, et al.
Hemoglobin
. 2024 Jan;
47(6):227-236.
PMID: 38189147
Sickle cell disease (SCD) affects 5% of the global population, with over 300,000 infants born yearly. In India, 73% of those with the sickle hemoglobin gene belong to indigenous tribes...